Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.
about
Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancersThe role of interleukin-6 in the human adrenal gland.The essence of senescence.The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study.Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype.Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrestA simple engineered platform reveals different modes of tumor-microenvironmental cell interaction.Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway.Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma.Spontaneous regression of pancreatic cancer: real or a misdiagnosis?Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma.Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cellsImmunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells.Termination of IL-6-induced STAT activation is independent of receptor internalization but requires de novo protein synthesis.A model for cancer-suppressive inflammationLong-term changes in the properties of skin-derived fibroblasts following irradiation of the head and neck.Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?Impact of Human Adipose Tissue-Derived Stem Cells on Malignant Melanoma Cells in An In Vitro Co-culture Model.Cytokines and cancer.Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.Comparison of adenoid cystic carcinomas arising from the parotid gland vs. the submandibular gland: focus on systemic metastasis and tumor-associated blood vessels.
P2860
Q33309944-763503A9-6926-4DFD-A0EE-8FD73AE90136Q33719793-44F4A8FB-3E23-4B61-A94D-8B08E84F2849Q34204071-169610AF-6FB2-4F76-8F68-9D8E7987E6ECQ34288983-F532C514-89C2-4F31-A539-08D970A78BABQ35396328-C5622576-5823-48FB-9C2C-8820B274D62AQ35763932-5B5E1AB3-83D0-4421-BF32-A4B8D5D298DFQ35833651-EB97335F-3008-4241-812F-0592F18129F7Q35978475-E9328DCC-1AF9-46FC-BB47-CFD92840DD2FQ36233022-1C595B24-F65B-419A-BE40-3403059A5E17Q36566521-C787CC92-D9F4-4357-9C28-43AF68A74F32Q36862918-9B826EE8-9D23-4F5A-BA63-ED7F620051AEQ36983666-AEFE3B9E-E964-432C-A969-9AE28BD8CFA8Q37100113-70C34E5C-4BC2-4931-883C-D0384EFAF417Q38021988-1BB07D15-6F4E-48A1-88D8-F8E57C2997A0Q38549236-117B458A-2262-4AC9-9ECB-38A5CC3E8358Q38585697-21137853-DE9D-4836-A999-972B84ADE836Q38870044-06A3522B-D20C-4C34-B8B0-BC36322367C4Q40701711-2353A5CC-4AFD-4E8A-A97B-6DA95DE11338Q40893109-CE7AC99F-7F92-4367-9F17-D1244482C15DQ41275639-5A4E45EB-8638-45FF-A04D-AE2C7C894897Q41617899-E66218D8-6F61-4A34-8306-54FC7060F6F7Q42855019-CA9866E7-203C-4CCA-B355-724D96BAEF6AQ44557733-8180484C-AF81-4B9F-83F1-E0C0ECBBB2F7Q45101917-9090FBB0-285B-486D-8592-1CC602E97132Q47611481-AB7F64E0-A35C-46AD-9FC1-D4ECFD98A5D5Q47912519-07B5EDE3-941C-4EFB-B32D-414B2C22D45BQ54104985-9646B2EA-BA3D-4962-93C1-A29B7A3FE51CQ54382585-DA11128F-91B2-4A4C-9D30-4A59AF489059
P2860
Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin 6: a fibroblast-de ...... d stages of tumor progression.
@en
Interleukin 6: a fibroblast-de ...... d stages of tumor progression.
@nl
type
label
Interleukin 6: a fibroblast-de ...... d stages of tumor progression.
@en
Interleukin 6: a fibroblast-de ...... d stages of tumor progression.
@nl
prefLabel
Interleukin 6: a fibroblast-de ...... d stages of tumor progression.
@en
Interleukin 6: a fibroblast-de ...... d stages of tumor progression.
@nl
P2093
P2860
P356
P1476
Interleukin 6: a fibroblast-de ...... d stages of tumor progression.
@en
P2093
P2860
P304
P356
10.1073/PNAS.89.19.9215
P407
P577
1992-10-01T00:00:00Z